Pakistan’s pharmaceutical industry achieved sales of Rs916 billion (USD 3.3 billion) in FY24, a 22% year-on-year (YoY) increase in PKR terms and a 7% YoY rise in USD terms, stated brokerage house Topline Securities, citing data from IQVIA, a leading healthcare data company. “This growth is also higher than the last five-year (FY20-FY24) CAGR [Compound […]
Read the full story at the Daily Times website.
